Evidence map›Paper›PMID 22520766›Full record

Trial reportThe British journal of general practice : the journal of the Royal College of General Practitioners2012

Difficulties in differential diagnosis of COPD and asthma in primary care.

Marc Miravitlles, Isabel Andreu, Yolanda Romero, Salvador Sitjar, Andreu Altés, Esther Anton

Open access · bronzeAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in The British journal of general practice : the journal of the Royal College of General Practitioners, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 96 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Integrating asthma care guidelines into primary care electronic medical records: a review focused on Canadian knowledge translation tools.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Primary care asthma surveillance: a review of knowledge translation tools and strategies for quality improvement.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2023
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Trends in Medicaid spending on inhalers in the United States, 2012-2018.Journal of managed care & specialty pharmacy · 2021
    Article
  20. GOLD 2021 Strategy Report: Implications for Asthma-COPD Overlap.International journal of chronic obstructive pulmonary disease · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Marc MiravitllesInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Ciber de Enfermedades Respiratorias (CIBERES), Hospital Clinic, Barcelona, Spain. marcm@separ.es
Isabel Andreu
Yolanda Romero
Salvador Sitjar
Andreu Altés
Esther Anton
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESPrimary Health Care · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic obstructive pulmonary disease (COPD) and asthma treatment must be based on appropriate diagnosis. However, patients receiving inhaled therapy in primary care may not be accurately diagnosed according to current guidelines.

aimTo analyse the characteristics of patients treated with inhaled medication, the concordance of tools for differential diagnosis, and the adequacy of prescription of inhaled corticosteroids (ICs) in primary care. DESIGN AND

settingCross-sectional, multicentre, non-interventional study conducted in 10 primary care centres in Barcelona, Spain.

methodPatients with chronic respiratory disease, aged >40 years were treated with ICs. They provided sociodemographic and clinical information and performed forced spirometry with a bronchodilator test (BDT). The diagnostic accuracy of asthma and COPD diagnoses were tested using two differential diagnosis questionnaires.

resultsA total of 328 patients were initially classified as having COPD (64.8%), asthma (15.4%), or indeterminate (19.8%) by their GPs. After spirometry, 40% of patients had moderate-severe airflow obstruction according to the GOLD classification; mean reversibility of forced expiratory volume in 1 second (FEV1) was 8.4%; 18.6% had a positive BDT; and 39.8% had post-bronchodilator FEV1/forced vital capacity >0.7. Concordance of the differential diagnosis tools was moderate (clinical diagnosis versus spirometry and between the two questionnaires), low (clinical diagnosis versus questionnaires), and very low (spirometry versus differential diagnosis). Of the patients diagnosed with COPD, 71.4% were treated with ICs, and 12% of those classified as having asthma were not receiving ICs.

conclusionMost patients can be classified as having COPD or asthma by primary care physicians. The use of the two questionnaires did not provide a better differential diagnostic compared with symptoms and spirometry with a BDT. Misdiagnosis may lead to inadequate treatment.

Indexed as

Administration, InhalationAdrenal Cortex HormonesAgedAsthmaBronchodilator AgentsCross-Sectional StudiesDiagnosis, DifferentialFemaleForced Expiratory VolumeHumansMaleMiddle AgedPrimary Health CarePulmonary Disease, Chronic ObstructiveVital CapacityAdrenal Cortex HormonesBronchodilator Agents

Identifiers

PMID22520766
PMCPMC3268496
OpenAlexW2034817972

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.